#weight-loss-drugs

Total 1 articles

Weight Loss Drug Titans: Novo's Fall, Lilly's Rise Signal Market Power Shift

While Novo Nordisk's stock plummets 17% on weak 2026 outlook, Eli Lilly soars 8% with explosive growth. The weight loss drug market crown is changing hands as scale trumps innovation.

Feb 4, 2026